JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Nordic American Tanker
NAT
$1.76B
| $7.69M | ﹤0.01% |
1,942,785
-1,114,295
| -36% | -$4M |
2015 Q1
32 quarters
|
|
2402
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.76B
| $7.69M | ﹤0.01% |
187,014
+85,258
| +84% | +$3.34M |
2014 Q1
36 quarters
|
|
2403
Carpenter Technology
CRS
$19.6B
| $7.68M | ﹤0.01% |
171,517
+94,330
| +122% | +$4.3M |
2013 Q2
39 quarters
|
|
2404
Supernus Pharmaceuticals
SUPN
$2.46B
| $7.67M | ﹤0.01% |
211,771
-31,084
| -13% | -$1.2M |
2015 Q4
29 quarters
|
|
2405
CALL
Kinder Morgan
KMI
$71.3B
| $7.64M | ﹤0.01% |
436,600
+18,500
| +4% | +$329K |
2014 Q3
34 quarters
|
|
2406
AMERISAFE
AMSF
$435M
| $7.64M | ﹤0.01% |
156,124
+126,258
| +423% | +$6.62M |
2013 Q2
39 quarters
|
|
2407
Oxford Industries
OXM
$385M
| $7.63M | ﹤0.01% |
72,255
+5,520
| +8% | +$617K |
2015 Q4
29 quarters
|
|
2408
CALL
Alcon
ALC
$30.6B
| $7.62M | ﹤0.01% |
108,000
-116,500
| -52% | -$8.29M |
2019 Q4
13 quarters
|
|
2409
Eastern Bankshares
EBC
$4.86B
| $7.61M | ﹤0.01% |
602,785
-735,010
| -55% | -$11.3M |
2020 Q4
9 quarters
|
|
2410
Dorian LPG
LPG
$2.42B
| $7.58M | ﹤0.01% |
380,027
-12,127
| -3% | -$247K |
2016 Q4
25 quarters
|
|
2411
4D Molecular Therapeutics
FDMT
$717M
| $7.57M | ﹤0.01% |
440,313
+339
| +0.1% | +$6.59K |
2021 Q1
8 quarters
|
|
|
AGNT
2412
AGNT Inc
AGNT
$660M
| $7.55M | ﹤0.01% |
595,278
+115,729
| +24% | +$1.54M |
2019 Q2
15 quarters
|
|
2413
M/I Homes
MHO
$3.4B
| $7.55M | ﹤0.01% |
119,750
+21,768
| +22% | +$1.25M |
2013 Q2
39 quarters
|
|
|
SHOE
2414
Shoe Station Group
SHOE
$350M
| $7.55M | ﹤0.01% |
294,326
+102,197
| +53% | +$2.67M |
2016 Q4
25 quarters
|
|
2415
Transmedics
TMDX
$2.82B
| $7.55M | ﹤0.01% |
99,675
+67,753
| +212% | +$4.69M |
2019 Q2
15 quarters
|
|
2416
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$490M
| $7.5M | ﹤0.01% |
211,544
+204,180
| +2,773% | +$7.06M |
2022 Q3
2 quarters
|
|
|
TERN
2417
DELISTED
Terns Pharmaceuticals
TERN
| $7.48M | ﹤0.01% |
631,746
-575,405
| -48% | -$5.5M |
2021 Q1
8 quarters
|
|
2418
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.79B
| $7.48M | ﹤0.01% |
219,989
-5,702
| -3% | -$199K |
2022 Q4
1 quarter
|
|
2419
CrossAmerica Partners
CAPL
$826M
| $7.47M | ﹤0.01% |
347,590
-58,881
| -14% | -$1.25M |
2022 Q3
2 quarters
|
|
2420
SK Telecom
SKM
$14B
| $7.47M | ﹤0.01% |
364,144
-1,032,042
| -74% | -$21.1M |
2013 Q2
39 quarters
|
|
2421
Brinker International
EAT
$8.14B
| $7.47M | ﹤0.01% |
196,521
+100,278
| +104% | +$3.8M |
2013 Q2
39 quarters
|
|
2422
CALL
VanEck Durable High Dividend ETF
DURA
$37M
| $7.46M | ﹤0.01% |
26,900
-7,700
| -22% | -$242K |
2021 Q3
6 quarters
|
|
|
CSGS
2423
DELISTED
CSG Systems International
CSGS
| $7.44M | ﹤0.01% |
138,570
+18,335
| +15% | +$1.04M |
2013 Q2
39 quarters
|
|
2424
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.4B
| $7.44M | ﹤0.01% |
73,604
+4,676
| +7% | +$478K |
2016 Q2
27 quarters
|
|
|
DQ
2425
Daqo New Energy
DQ
$750M
| $7.41M | ﹤0.01% |
158,127
+310
| +0.2% | +$14.2K |
2019 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.